Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Learn why index funds are a practical choice for long-term investing, emphasizing diversification, low fees, and a hands-off approach for steady growth.
28,023 articlesA long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Federal economists say tariffs are unlikely to be a one-off hit. Instead, a trump created ‘trickle up’ pricing approa...
Netflix revealed it used AI to speed production on a documentary, delivering 17 minutes of AI-enhanced footage at hal...
Democratic lawmakers are pushing the DOJ to reopen or strengthen antitrust scrutiny of the $1.6 billion Compass-Anywh...
February delivered the first drop in health care payrolls in more than four years, signaling a shift in a market that...
Oil breaks $100 again as Middle East tensions flare, lifting energy stocks and reshaping risk-on bets for 2026. Inves...
Anthropic confirms it is testing a new AI model after a data leak exposed its existence. The company says early acces...
The Clarity Act is moving toward markup with more than 100 amendments, spotlighting a fierce clash over stablecoin re...
MoonPay seals its fourth acquisition of the year, bringing Decent into the fold as it launches MoonPay Trade to strea...
April data show 7.6 million job openings, up from March as hiring slows and layoffs drop. The report highlights a sti...
XRP led gains in a choppy week, yet traders say ripple’s (xrp) breakout isn’t real until it clears the critical ceili...
Apple quietly hiking prices on Mac and iPad models signals a shift in pricing strategy as memory costs rise, with inv...